Columbia Research Enhanced Value ETF (REVS) Dividend Yield, History & Forecast

Columbia Research Enhanced Value ETF (REVS) is an exchange-traded fund (ETF) listed on the New York Stock Exchange Arca. It pays a current dividend yield of 1.80% ($0.60 per share annually (TTM)). The most recent ex-dividend date was December 18, 2025, with payment scheduled for December 26, 2025. market capitalization is approximately $347M. Review REVS dividend history on this scorecard, compare peers in the Compare Dividend Returns tool, or project income with the dividend calculator.

REVS fund composition

REVS holds 308 positions, with 33.1% of assets in its ten largest. It charges an expense ratio of 0.20%, and manages $348.3M.

Top 10 holdings

HoldingWeight
AAPLAPPLE INC8.24%
MSFTMICROSOFT CORP7.14%
BACBANK OF AMERICA CORP3.82%
CVXCHEVRON CORP2.88%
MOALTRIA GROUP INC2.22%
CCITIGROUP INC1.89%
METAMETA PLATFORMS INC1.87%
BMYBRISTOL-MYERS SQUIBB CO1.81%
SCHWCHARLES SCHWAB CORP/THE1.64%
CSCOCISCO SYSTEMS INC1.58%

Sector allocation

Technology22.6%Financial Services17.9%Healthcare12.6%Consumer Cyclical9.6%Industrials8.4%Consumer Defensive7.1%Energy5.5%Basic Materials3.7%Other12.7%

Frequently Asked Questions about Columbia Research Enhanced Value ETF (REVS)

What is Columbia Research Enhanced Value ETF's dividend yield?
Columbia Research Enhanced Value ETF (REVS) pays a current trailing twelve-month dividend yield of 1.80%, which works out to $0.60 per share annually based on the most recent payout schedule.
When does Columbia Research Enhanced Value ETF pay distributions?
The most recent ex-dividend date was December 18, 2025. The next scheduled dividend payment date is December 26, 2025.
How many years has Columbia Research Enhanced Value ETF increased its dividend?
Columbia Research Enhanced Value ETF (REVS) has increased its dividend for 1 consecutive year.
What does Columbia Research Enhanced Value ETF invest in?
The fund invests at least 80% of its assets in the securities of the index. The index reflects a rules-based strategic beta approach to investing in the companies that comprise the Russell 1000® Value Index, designed to achieve stronger total return when compared to the Russell 1000® Value Index, which is a broad measure of the performance of U.S. large- and mid-cap value companies.